Cross Country Healthcare buy melinda
Start price
05.09.12
/
50%
€3.54
Target price
05.03.13
€4.00
Performance (%)
23.42%
End price
05.03.13
€4.36
Summary
This prediction ended on 05.03.13 with a price of €4.36. The BUY prediction by melinda finished with a performance of 23.42%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Cross Country Healthcare | 2.290% | 2.290% | -44.628% | 3.876% |
iShares Core DAX® | -0.530% | 2.858% | 15.472% | 17.034% |
iShares Nasdaq 100 | -0.580% | 4.871% | 28.534% | 54.277% |
iShares Nikkei 225® | -1.097% | -1.658% | 7.461% | 3.656% |
iShares S&P 500 | -0.730% | 2.647% | 24.918% | 45.236% |
Comments by melinda for this prediction
In the thread Cross Country Healthcare diskutieren
klinischen Studien
Langlauf und Gesundheitsdienstleister von klinischen Studien andere Dienste Human Capital Management konzentriert sich auf Gesundheits-
(Laufzeit überschritten)
Stopped prediction by melinda for Cross Country Healthcare
Cross Country Healthcare
Start price
Target price
Perf. (%)
€7.30
21.12.13
21.12.13
€5.50
23.06.14
23.06.14
-34.93%
23.06.14
23.06.14